Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02729948 · ClinicalTrials.gov registry record · NA

Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT02729948: Completed NA study, sponsored by University of Washington.

NCT02729948 is a NA study that has completed, run by University of Washington. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02729948, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

This pilot clinical trial studies how well tethered capsule endoscope works in screening patients with Barrett esophagus (BE), a condition where the lining of the esophagus has changed or has been replaced with abnormal cells that may lead to cancer also called esophageal cancer. In an attempt to prevent the progression from BE to esophageal cancer, patients undergo a standard procedure called esophagogastroduodenoscopy (EGD) where patients are sedated and the doctor uses an endoscope to examine the tissue in the esophagus. Tethered capsule endoscope is a tiny capsule with a laser scan inside and a very thin cord attached to it. Patients swallow the capsule and the thin cord keeps the capsule in specific area in the esophagus. After pictures of the lining of esophagus are taken, the capsule is removed using the thin cord. Tethered capsule endoscope may be able to identify tissue changes in patients with BE without the need for sedation or anesthesia, thus eliminating the associated risks and costs associated with EGD.

Primary Outcome

Consistent image quality defined as no significant degradation of lateral spatial resolution \[line pairs per mm\] and axial depth of focus \[mm\], maximum field of view \[degrees cone angle\], and color fidelity \[qualitatively matches color chart\] when measured after use in the clinic using color and resolution test targets and a test chamber to measure field of view. The standard care EGD will be digitally recorded to allow for review and comparison to the TCE procedure by a blinded, expert

Interventions

  • OTHER Survey Administration
  • DEVICE Tethered Capsule Endoscope

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2016-07-28
Est. Completion 2017-08-03
Phase NA
University of Washington

1,048 total trials

What the finished NCT02729948 record still lists

NCT02729948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.

NCT02729948 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02729948 about?

NCT02729948 is a clinical study titled "Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus". This pilot clinical trial studies how well tethered capsule endoscope works in screening patients with Barrett esophagus (BE), a condition where the lining of the esophagus has changed or has been replaced with abnormal cells that may lead to cancer also called esophageal cancer. In an attempt to pr...

What is the current status of trial NCT02729948?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2016-07-28. Estimated completion is 2017-08-03.

What interventions are being tested in trial NCT02729948?

The interventions under investigation include: Survey Administration (OTHER), Tethered Capsule Endoscope (DEVICE).

Who is sponsoring clinical trial NCT02729948?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02729948's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02729948, the US trial registry maintained by the National Library of Medicine. NCT02729948 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.